HIGH

Boothwyn Pharmacy Recalls Semaglutide Injection Due to Potency Issues

Boothwyn Pharmacy recalled 648 vials of Semaglutide injection on July 9, 2025. The product is subpotent and poses a high hazard risk. Consumers should stop using the product immediately and contact their healthcare provider.

Quick Facts at a Glance

Recall Date
July 9, 2025
Hazard Level
HIGH
Brand
Boothwyn Pharmacy
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Subpotent Drug

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Boothwyn Pharmacy LLC or your healthcare provider for guidance. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Product Details

The recall pertains to Semaglutide, 2.5 mg/mL injection, packaged in 4 mL vials. Models include 03202025@2, 03202025@3, and 03202025@4 with a use-by date of July 18, 2025. The product was distributed nationwide in the U.S.

The Hazard

The recalled Semaglutide injection is classified as subpotent. This could lead to inadequate treatment for conditions it is prescribed for, potentially resulting in serious health risks.

Reported Incidents

No injuries or incidents have been reported at this time. The potential for health complications remains a concern due to the drug's subpotency.

What to Do

Stop using the recalled Semaglutide injection immediately. Contact Boothwyn Pharmacy LLC or your healthcare provider for guidance on alternative treatments.

Contact Information

For more information, contact Boothwyn Pharmacy at their official channels or visit their FDA recall page.

Key Facts

  • Recall Date: July 9, 2025
  • Quantity Recalled: 648 vials
  • Classification: Class II
  • Hazard Level: High

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
03202025@2
03202025@3 and 03202025@4 BUD 07/18/2025
Affected States
ALL
Report Date
September 10, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more